Similar to systemic lupus erythematosus, elevated BAFF signaling promotes the inflammatory RA microenvironment and antagonists have shown promising efficacy in the treatment of RA [41,45]. The gene discussed is TNFSF13B; the disease is systemic lupus erythematosus.